Join Us for the 2024 Colorado Privacy Summit on September 26th!

Read more
  • Contact Us
Contact Us
Businessman hold of global structure leveraging network technology to optimize performance and drive decision-making through data analytics. This allows for enhanced insights into market trends.
Blog

We leverage our deep clinical and commercial expertise, supported by an intensive, field-oriented research approach, to address the most complex business challenges. Explore our unique perspectives, innovative methodologies, and the critical insights we provide to help our clients navigate their most pressing issues. Explore our collection of Insights and Resources below to learn more about our unique approach at SAI Med Partners. 

Most Recent

Blog

2026 Freshness Index

Blog

IDEA Pharma is a proud partner of Candel Therapeutics

Blog

Creating the Right Answer: The Fulcrum EVOLVE™ Framework for Pharmaceutical Positioning 

Filter By

All Types
All Solutions
view results
Clear all filters

All Resources

Erik Coats Interview Blog
Blog

Minimizing Bias in Market Research: An Interview with Erik Coats

Minimizing Bias in Market Research: An Interview with Erik Coats By The Fulcrum Research Division Erik Coats is one of […]

Read Post
2025 Digital Innovation Index Winner (1200 x 800 px) (1000 x 600 px)
Blog

2025 Collaborating for Novel Solutions (CNS) Summit: Annual Pharma Digital Innovation Index, cements leaders in the Biopharmaceutical innovation of digital solutions.

Tuesday, November 4th, 2025, Boston, MA – Today, the annual Pharmaceutical Digital Innovation Index, a partnership between IDEA Pharma, a […]

Read Post
Untitled design
Blog

Challenges and Concerns Raised by EFPIA on Joint Clinical Assessments

In the healthcare regulation sphere, proposed EU-level joint clinical assessments (JCAs) have sparked debate in the pharmaceutical industry. A recent EFPIA report highlights concerns about the rigidity of the guidelines, particularly in oncology, and suggests revisions to ensure a more
Read Post
Pen Writting
Blog

Joint Clinical Assessment (EU HTA) Explained

A Comprehensive Exploration of Competitive Intelligence, Knowledge-Sharing, and Strategic Optimization in the Evolving Landscape of EU Health Technology Assessments. The […]

Read Post
Untitled-design-7-1
Blog

Rare Disease Day: Uniting Compassion, Data, and Global Action for Accessible Healthcare

What rare disease day means for our work at SAI Every leap year, on the 29th of February, the world […]

Read Post
Untitled design
Blog

SAI MedPartners Expands Strategic Investments: Driving Growth and Elevating Consultancy Excellence

In the dynamic world of pharmaceutical services, strategic investments play a vital role in shaping the future of organizations. We are happy to announce that we have recently made headlines with our strategic acquisitions of Fulcrum Research Group (FRG) and
Read Post
Untitled design
Blog

The Evolving World of Social & Digital Media Intelligence

It is no secret that social media is an essential channel for expressing opinions and sharing facts. Depicted through visual representations and the written word, the world works fundamentally through online channels, without which we would be thrown back into
Read Post
Hemoglobin Blog
Blog

Challenges in Hemoglobinopathies Projects and the Support of KOL Match

There are over 7,000 rare diseases described, affecting about 20-30 million people in the U.S. alone, according to the NIH. While each condition has its specificities, there are common challenges in the rare disease space, such as finding patients and
Read Post
Conference Blog Opt. 5
Blog

Conference coverage with SAI: from intelligence to insight, from insight into actionable business decisions

Medical conference coverage requires both knowledge of the therapeutic area and the ability to synthesize key points from several individual sessions into nuanced, meaningful intelligence. At SAI, we compile the pertinent data presented at the conference, provide key takeaways from
Read Post
intermediate_image
Blog

Cell Therapy: A View Towards Advantages and Disadvantages of Four Approaches

Immune effector cell (IEC) therapies, commonly referred as cell therapies, utilize human cells to cause or enhance an immune response against tumor cells. Following remarkable successes with several patients in the early 2010s – most notably, the case of Emily
Read Post

Let’s Talk Business

contact us

Explore our Related Solutions: Delve Deeper

Gain further understanding of our range of related solutions and offerings by exploring each topic individually. 

Competitive Intelligence

Learn More

Market Research

Learn More

Strategic Consulting

Learn More
Scroll to Top